Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

5.97
Delayed Data
As of Feb 16
 -0.06 / -1.00%
Today’s Change
1.82
Today|||52-Week Range
6.24
+61.79%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues8.0M5.7M3.1M2.5M
 
 
 
 
 
Depreciation And Amortization20.0K29.0K27.0K11.0K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses39.7M50.7M42.3M39.0M
 
 
 
 
 
Research And Development28.9M27.7M23.7M22.9M
 
 
 
 
 
Total Operating Expenses39.7M50.8M42.4M39.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-31.8M-45.0M-39.3M-36.5M
 
 
 
 
 
Extraordinary Credit96.0K3.9M3.5M0.00
 
 
 
 
Interest Expense On Debt2.9M1.7M939.0K1.7M
 
 
 
 
 
Other Expenses-4.0K-132.0K22.0K158.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-34.6M-43.0M-36.7M-38.0M
 
 
 
 
 
Net Income-34.6M-43.0M-36.7M-38.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS8.7M10.0M12.2M15.7M
 
 
 
 
 
Shares To Calculate EPS Diluted8.7M10.3M12.2M15.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$3.96-$4.56-$3.00-$2.42
 
 
 
 
 
EPS Diluted-$3.96-$4.56-$3.00-$2.42